Overview Financials News + Filings
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K/A | 10-K/A |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
Revenue growth | | | -100.0% | 4159.7% | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
Gross margin | | | | 100.0% | 100.0% | |
Selling, general and administrative [+] | 0.0 | 0.0 | 0.0 | | 0.1 | 0.0 |
Sales and marketing | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
General and administrative [+] | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Professional fees | 0.0 | 0.0 | 0.0 | | | |
Rent expense | | | | | 0.0 | 0.0 |
Other selling, general and administrative | 0.0 | 0.0 | 0.0 | | 0.1 | 0.0 |
Research and development | | | | | 0.0 | |
Other operating expenses | 0.0 | 0.0 | 0.0 | 0.1 | 0.6 | 0.1 |
EBIT [+] | -0.1 | 0.0 | -0.1 | 0.0 | -0.3 | -0.1 |
EBIT growth | 39.7% | -47.5% | 106.1% | -87.3% | 180.0% | |
EBIT margin | | | | -100.0% | -99.7% | |
Non-recurring items [+] | | | | | 0.0 | |
Unusual expense | | | | | 0.0 | |
Other income (expense), net [+] | 0.0 | 0.0 | | | 0.0 | |
Other non-ooperating expenses | | 0.0 | | | | |
Other | 0.0 | 0.0 | | | | |
Pre-tax income | -0.1 | 0.0 | -0.1 | 0.0 | -0.3 | -0.1 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.1 | 0.0 | -0.1 | 0.0 | -0.3 | -0.1 |
Net margin | | | | -100.0% | -99.7% | |
|
Basic EPS [+] | $0.00 | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) |
Growth | 39.6% | -49.1% | 103.1% | -87.6% | 179.4% | |
Diluted EPS [+] | $0.00 | $0.00 | $0.00 | $0.00 | ($0.01) | ($0.01) |
Growth | 39.6% | -49.1% | 103.1% | -87.6% | 179.4% | |
|
Shares outstanding (basic) [+] | 20.0 | 19.8 | 19.7 | 19.4 | 19.0 | 18.9 |
Growth | 1.0% | 0.6% | 1.5% | 2.2% | 0.2% | |
Shares outstanding (diluted) [+] | 20.0 | 19.8 | 19.7 | 19.4 | 19.0 | 18.9 |
Growth | 1.0% | 0.6% | 1.5% | 2.2% | 0.2% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|